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ABSTRACT
Study Design: Cross-sectional. Objective: Estimating the prevalence of hypovitaminosis D in a group of seve-
rely obese subjects referred to bariatric surgery. Methods: This study evaluated severely obese patients aged 
≥18 years assisted by a specialized team in bariatric surgery. Clinical, anthropometric, and laboratory data were 
obtained from patient records. Plasma 25 (OH) D was determined by chemiluminescence and levels ≤ 20 ng/mL 
was considered as Hypovitaminosis D. The data were analyzed using the Statistical Package for Social Scien-
ces® (SPSS) 20.0. Variables were described using descriptive statistics. For the comparison of the three groups, 
ANOVA, Kruskal-Wallis, and Pearson’s chi-square tests were used. Spearman correlation test was performed to 
assess correlations between 25(OH)D and the other variables. P-values <0.05 were considered to be significant. 
Results: The study included 400 individuals, 71% were female with the mean age (SD) and BMI (SD) of 35.6 (9.1) 
years and 41.4 (5.1) kg/m², respectively. The vitamin D ranged from 4.5 to 62.4 ng/mL and the mean (SD) was 24.7 
(7.9) ng/mL. In this sample, 117 (29.3%) individuals had hypovitaminosis D. There was a negative correlation 
between 25(OH)D and BMI (r= -0.110; p=0.028) and parathormone (r= -0.152; p=0.006) and positive correlation 
with serum calcium (r= 0.132; p=0.013) and phosphorus (r= 0.116; p=0.027). Conclusion: Severely obese sub-
jects had a high prevalence of hypovitaminosis D even living in a sunny state.
Keywords: Vitamin D Deficiency; Vitamin D; Obesity; Bariatric Surgery; Adult.
RESUMO 
Modelo do estudo: Estudo transversal. Objetivo: estimar a prevalência da hipovitaminose D em um grupo de 
obesos graves encaminhados à cirurgia bariátrica. Métodos: Foram estudados obesos atendidos por uma equipe 
especializada em cirurgia bariátrica, com 18 anos ou mais de ambos os sexos. Dados clínicos, antropométricos e 
laboratoriais foram obtidos dos prontuários dos pacientes. A 25 (OH) D plasmática foi determinada por quimiolu-
minescência e valores ≤20 ng/mL foram considerados como hipovitaminose D. Os dados foram analisados  utilizan-
do o Statistical Package for the Social Sciences® (SPSS) 20.0. Estatística descritiva foi utilizada para apresentação 
das variáveis e para comparação dos três grupos foram utilizados os testes: ANOVA, Kruskal-Wallis e qui-quadrado 
de Pearson. Foram considerados estatisticamente significantes valores de p<0,05. Resultados: Foram estudados 
400 pacientes, 71% do sexo feminino, com média (DP) de idade e IMC 35,6 (9,1) anos e 41,4 (5,1) kg/m², respec-
tivamente. A vitamina D variou de 4,5 a 62,4ng/mL com média (DP) de 24,7 (7,9) ng/mL. Na amostra, 117 (29.3%) 
dos pacientes apresentaram hipovitaminose D. Houve correlação negativa entre 25 (OH) D e IMC (r = -0,110; 
p = 0,028) e paratormônio (r = -0,152; p=0,006) e correlação positiva com cálcio sérico (r=0,132; p = 0,013) 
e fósforo (r=0,116; p=0,027). Conclusão: Os obesos graves apresentaram alta prevalência de hipovitaminose D, 
mesmo vivendo em um estado ensolarado.
Palavras-chave: Deficiência de Vitamina D; Vitamina D; Obesidade; Cirurgia Bariátrica; Adulto.
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INTRODUCTION
Vitamin D, a pro-hormone, has an import-
ant and well-established role in the metabolism of 
calcium and phosphorus. Evidence suggests that 
its deficiency may also be associated with the de-
velopment of metabolic syndrome, diabetes, and 
some types of cancer1,2.
Hypovitaminosis D has been reported 
throughout the world, even in areas with a high in-
cidence of ultraviolet radiation (UV) and in devel-
oped countries, where vitamin D food fortification 
was implemented years ago2. A systematic review 
by Hilger et al.1 showed that 37.3% of the global 
population had levels of serum 25-hydroxyvita-
min D (25-OH-D) below 50 nmol/L (<20ng/mL) 
and 6.7% below 25 nmol/L (<10 ng/mL). Unger 
et al.3 found a prevalence of hypovitaminosis D 
(<30 ng/mL) in 77.4% of healthy Brazilian adults. 
However, the cutoff for determining the op-
timal vitamin D level is still under debate. The 
clinical practice committee of the European Cal-
cified Tissue Society (ECTS)4 and Endocrine So-
cieties5 recommend values >20 ng/mL for the 
healthy population. Brazilian medical societies in 
2018 adopted this cutoff point and suggested that 
groups at risk such as obese patients undergoing 
bariatric surgery should maintain values  between 
30-60 ng/mL of serum vitamin D6.
It is well recognized that skin pigmentation, 
use of sunscreen, air pollution, old age, and obe-
sity are related to hypovitaminosis D2. Obese indi-
viduals tend to have low levels of 25-OH-D and it is 
inversely associated with Body Mass Index (BMI) 
and body fat percentage. The decrease in vitamin 
D bioavailability in obesity is believed to be due to 
the storage (deposition) of this fat-soluble vita-
min in adipose tissue. Besides, obese people use 
to have low sun exposure2,3,7. Obinwanne et al.8 
evaluated 34 American women in pre-bariatric 
surgery (BMI ≥ 35.0Kg/m²) and found hypovita-
minosis D (<25 ng/mL) in 55% of them. 
Considering the increasing worldwide prev-
alence of obesity, its association with hypovita-
minosis D and the possible secondary osteomet-
abolic impact of this condition, this study aimed 
to estimate the prevalence of this deficiency in a 
group of severely obese adults referred for bariat-
ric surgery, with high levels of miscegenation in a 
city with high solar irradiation.
MATERIAL AND METHODS
This is a cross-sectional study with severely 
obese subjects (BMI ≥35.0 kg/m²) referred for ba-
riatric surgery. The study was conducted in a refe-
rence center for the treatment of obesity in Salvador, 
Bahia, located in the tropical zone of the Brazilian 
northeast coast (latitude of -12° 58’ 16’’ S).
The sample size of 194 individuals was 
calculated considering that the prevalence of 
hypovitaminosis D in obese patients submitted 
to bariatric surgery was 55%8, with a precision 
of 7% and alpha of 5%. Consecutive patients 
treated between 2014 and 2016 were included. 
Exclusion criteria were incomplete data; vitamin 
D determination method different from chemilu-
minescence; use of parathormone (PTH) or other 
drugs that interfere with vitamin D metabolism; 
patients with hyperparathyroidism and hepatic or 
renal disease.
The variable 25 (OH) D was stratified into 
three different groups so that we could analyze 
the results according to different studies. Conside-
ring ECTS4, suitable values are above 20.0 ng/mL 
following the new position European Society of En-
docrinology, vitamin D limits were stratified in de-
ficiency (<12.0 ng/mL), insufficiency (from 12.0 
to 20.0 ng/mL), and sufficiency (>20.0 ng/mL)5. 
In this study, hypovitaminosis D was defined by 
serum levels of vitamin D ≤20 ng/mL as recom-
mended by the Brazilian societies. 
Hypertensive and diabetic patients were 
those who referred by the medical diagnosis or 
those who were using specific medications. De-
mographic (age and gender), anthropometric 
(weight, height, and body mass index), and bio-
chemical (serum total calcium, phosphorus, urea, 
creatinine, alkaline phosphatase, and PTH) varia-
bles were collected from medical reports.
The variable “use of vitamin D” was infor-
med by the participants and defined as any use 
of it, alone or in association with other vitamins, 
independent of dose and time of use.
Data analysis was performed with the IBM 
SPSS Statistics software package, version 20.0 
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(IBM Corporation, Armonk, NY, USA). Variables 
were described using descriptive statistics (mean 
or median and standard deviation or interquartile 
interval). For the comparison of the three groups, 
ANOVA, Kruskal-Wallis, and Pearson’s chi-square 
tests were used according to the variable. Spear-
man correlation test was performed to assess cor-
relations between 25(OH)D and the other variables. 
P-values <0.05 were considered to be significant.
The project was approved by the Hu-
man Research Ethics Committee of the Nutrition 
School of the Federal University of Bahia under 
N°. 1.296.1592/2016. 
RESULTS
The study included 400 individuals referred 
for bariatric surgery with a mean age (standard 
deviation) of 35.6 (9.1) years and 71% of them 
were female. Regarding the presence of chronic 
diseases, 33 (8,3%) of the participants had dia-
betes and 147 (36.8%) had arterial hypertension. 
BMI ranged from 35.0 to 60.3 kg/m², an average 
(SD) of 41.4 (5.1) kg/m² and 52.3% (209 indivi-
duals) were classified as grade III of obesity. Tab-
le 1 shows the demographic and clinical characte-
ristics according to 25 OH vitamin D serum levels. 
Table 1
Clinical and demographic characteristics of 400 severely obese subjects according to 25 OH vitamin D serum levels.








Female 400 86 (73.5%) 132 (67.0%) 66 (76.7%) 0.196
Age (years)* 400 35.4 (9.2) 35.7 (8.9) 35.6 (9.3) 0.954
BMI (Kg/m²)* 400 41.7 (5.0) 41.6 (5.2) 40.6 (5.1) 0.244
Phosphorus (mg/dL)* 365 3.6 (0.5) 3.7 (0.6) 3.8 (0.6) 0.111
Total calcium (mg/dL)* 359 9.1 (0.4) 9.2 (0.5) 9.2 (0.5) 0.088
PTH (pg/mL) † 328 36.9 (24.8-47.7) 31.3 (22.9-39.8) 29.5 (21.4-38.5) 0.013
Alkaline phosphatase (U/L)† 361 77.0 (62.0-115.0) 78.0 (65.0-98.8) 74.0 (61.0-91.3) 0.163
Creatinine (mg/dL)* 383 0.7 (0.2) 0.7 (0.2) 0.7 (0.1) 0.473
Urea (mg/dL)* 386 27.0 (7.3) 26.5 (7.5) 27.4 (6.6) 0.625
*Data expressed as mean and standard deviation; †median and inter-quartile range; BMI, body mass index; PTH, parathyroid hormone. 
To calculate serum calcium, the patients with low albumin levels were excluded.
Vitamin D ranged from 4.5 to 62.4 ng/mL 
with an average (SD) of 24.7 (7.9) ng/mL, 
and 117 (29.3%) had hypovitaminosis D. 
There was a negative and statistically signifi-
cant correlation among vitamin D, BMI (r = -0.110; 
p= 0.028), and PTH (r = -0.152; p= 0.006), while 
a positive correlation was found between serum 
phosphorus (r = 0.116; p= 0.027) and calcium 
(r = 0.132; p= 0.013). 
DISCUSSION
This study showed a high prevalence of 
hypovitaminosis D in this group of obese patients 
and a negative linear association among vitamin D, 
BMI, and PTH, and a positive association between 
serum phosphorus and calcium.
Unger et al.3 evaluated 603 healthy adults 
with a mean age of 47.8 years and an average 
BMI of 27.2kg/m², in a region of Brazil where the 
differences between seasons are more defined and 
found a prevalence of hypovitaminosis D (<30ng/
mL) of 37.3% during the summer. This frequency, 
below the present study, might be justified by the 
difference between the BMI of the individuals since 
our study included only severely obese patients. 
According to the International Federation 
for the Surgery of Obesity and Metabolic Disorders 
(IFSO), from 2014-2018 the patients’ median BMI 
pre-surgery was 41.7 kg/m2 (interquartile range 
38.3-46.1 kg/m2). There was wide variation betwe-
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en countries, with medians ranging from 34.2 kg/m2 
in South Korea to 49.1 kg/m2 in Germany9.
Other researchers studied patients with se-
vere obesity (BMI ≥ 35.0 kg/m²) in regions with 
different latitudes and used similar cutoff points to 
25(OH)D and found similar results. In Spain, Moizé 
et al.10 evaluated 231 obese individuals and found 
a prevalence of hypovitaminosis D (<20 ng/mL) in 
67.7% of them. Aridi et al.11 showed a prevalen-
ce of hypovitaminosis D in 91.5% of patients with 
obesity I or II in Lebanon, and 68.9% of them had 
levels below 20 ng/mL of this vitamin. 
It is essential to differentiate vitamin D nu-
tritional guidelines for the general population (such 
as ECTS) from clinical vitamin D guidelines for pa-
tient care. According to the Brazilian societies, the 
optimal 25 (OH) D values for a healthy population 
(up to 60 years of age) are above 20 ng/mL and 
between 30 and 60 ng/mL for at-risk groups4,7,12,13.
The negative correlation between vita-
min D and BMI can be related to the seques-
tration (storage) of this fat-soluble vitamin by 
adipocytes, reducing its bioavailability1-3. This 
correlation was also observed by Moizé et al.10 
(r=-0.234; p <0.05) for females. As expected, 
PTH was inversely correlated with 25(OH) D, 
whereas there was a positive correlation betwe-
en this and calcium and phosphorus. It is known 
that as the concentration of 1.25-dihydroxyvita-
min D rises, the intestinal absorption and renal 
reabsorption of phosphorus increase. The 25(OH)
D deficiency leads to the serum calcium levels re-
duction, resulting in secondary hyperparathyroi-
dism and inadequate mineralization or skeletal 
demineralization1,3,10.
A convenience sample is one of the limita-
tions of this study, nevertheless, the patient pro-
file is similar to those of many obesity treatment 
centers. Comparison with other studies is one of 
the limitations of this study, as there is no uni-
formity of vitamin D normal values. This is also a 
limitation of other studies due to the lack of con-
sensus on the optimal serum value of this vitamin. 
The vitamin D dosage method was standardized to 
ensure the internal validity of the study, however, 
the dosages have not been performed in the same 
laboratory and we cannot guarantee that the tests 
belonged to the same manufacturer, which may in-
terfere with the variability in the 25- OHD.
In conclusion, this study showed that seve-
rely obese subjects had a high prevalence of hypo-
vitaminosis D suggesting that these patients deser-
ve greater attention by health care professionals, 
even in sunny countries. Considering that after ba-
riatric surgery it is difficult to maintain adequate 
levels of vitamin D, as well as other micronutrients, 
it would be interesting to reach levels between 30 
and 60 ng/mL already in the preoperative period.
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